Hetlioz, created in 2011 (United States), from 9 sister brands and 2214 competing brands. The Hetlioz brand is owned by Vanda Pharmaceuticals, a company listed in New York. Hetlioz belongs to the Biotechnology business sector.

Hetlioz is a brand of Vanda Pharmaceuticals (VNDA) Share price

International deposit : 2011 Business sector Biotechnology

Share price and profitability of the share Vanda Pharmaceuticals (Hetlioz)

Buy Vanda Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 4.63

Portfolio valuation
Vanda Pharmaceuticals (Hetlioz) over 5 years* USD 1.27

Stock market history Vanda Pharmaceuticals (Hetlioz)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Vanda Pharmaceuticals

Vanda Pharmaceuticals
Vanda Pharmaceuticals
See more brands of Vanda Pharmaceuticals

Rival brands
Hetlioz

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS